Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in June - Earnings Summary

Sonnet Biotherapeutics Holdings

15/08/2022 23:23

* Sonnet Biotherapeutics Holdings Inc  SONN.OQ  reported a
quarterly adjusted loss of 13 cents​​ per share for the quarter
ended in June. The mean expectation of two analysts for the
quarter was for a loss of 14 cents per share.
    * Revenue was $62.07 thousand​; analysts expected $50.00
thousand. 
    * Sonnet Biotherapeutics Holdings Inc's reported EPS for the
quarter was a loss of 13 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Sonnet Biotherapeutics Holdings Inc shares had risen
by 6.4%
this quarter and lost 27.9% so far this year.
    * The company reported a quarterly loss of $7.88 million.
    * Wall Street's median 12-month price target for Sonnet
Biotherapeutics Holdings Inc is $2.25 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 10:23 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.14          -0.13          Beat
 Mar. 31 2022      -0.12          -0.14          Missed
 Dec. 31 2021      -0.19          -0.10          Beat
 Sep. 30 2021      -0.22          -0.17          Beat